Gold nanoparticle-based nanoprobes with enhanced tumor targeting and photothermal/photodynamic response for therapy of osteosarcoma
Abastract
Plasmonic nanomaterials, especially a wide variety of gold nanoparticles, demonstrate great potential for theranostics of cancer. Herein, a gold nanotriangle with CD133 and hyaluronic acid on its surface loaded with a near-infrared photosensitizer was prepared for enhanced photodynamic/photothermal combined anti-tumor therapy. CD133 and hyaluronic acid provide the nanoprobe with dual tumor targeting, while the hyaluronic acid also protects photosensitive drugs from photodegradation. Thus, the nanoprobe has enhanced photothermal/photodynamic effects. This integrated treatment strategy significantly enhanced photodynamic/photothermal destruction of osteosarcoma cells. In addition, this treatment, induced by mild irradiation with a single wavelength laser, inhibited tumor growth in an osteosarcoma mouse model. These results indicate that this systemic treatment strategy can achieve enhanced anti-tumor therapeutic effects through active tumor targeting and protection of the loaded drugs.
Top-30
Journals
|
1
2
|
|
|
Bioactive Materials
2 publications, 7.69%
|
|
|
Small
1 publication, 3.85%
|
|
|
Frontiers in Molecular Biosciences
1 publication, 3.85%
|
|
|
Frontiers in Pharmacology
1 publication, 3.85%
|
|
|
Frontiers in Oncology
1 publication, 3.85%
|
|
|
Photodiagnosis and Photodynamic Therapy
1 publication, 3.85%
|
|
|
Drugs and Drug Candidates
1 publication, 3.85%
|
|
|
Environmental Research
1 publication, 3.85%
|
|
|
Current Cancer Therapy Reviews
1 publication, 3.85%
|
|
|
Chemical Society Reviews
1 publication, 3.85%
|
|
|
Journal of Materials Chemistry B
1 publication, 3.85%
|
|
|
Orthopaedic surgery
1 publication, 3.85%
|
|
|
Molecular Cancer
1 publication, 3.85%
|
|
|
Oncology Reports
1 publication, 3.85%
|
|
|
Biomaterials Research
1 publication, 3.85%
|
|
|
ACS Omega
1 publication, 3.85%
|
|
|
International Journal of Molecular Sciences
1 publication, 3.85%
|
|
|
Science China Chemistry
1 publication, 3.85%
|
|
|
Communications Materials
1 publication, 3.85%
|
|
|
Nanomaterials
1 publication, 3.85%
|
|
|
Nano Biomedicine and Engineering
1 publication, 3.85%
|
|
|
Coordination Chemistry Reviews
1 publication, 3.85%
|
|
|
Russian Chemical Reviews
1 publication, 3.85%
|
|
|
Scientific African
1 publication, 3.85%
|
|
|
Microchimica Acta
1 publication, 3.85%
|
|
|
1
2
|
Publishers
|
1
2
3
4
5
6
7
|
|
|
Elsevier
7 publications, 26.92%
|
|
|
Springer Nature
5 publications, 19.23%
|
|
|
Frontiers Media S.A.
3 publications, 11.54%
|
|
|
MDPI
3 publications, 11.54%
|
|
|
Wiley
2 publications, 7.69%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 7.69%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 3.85%
|
|
|
Spandidos Publications
1 publication, 3.85%
|
|
|
American Chemical Society (ACS)
1 publication, 3.85%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 3.85%
|
|
|
1
2
3
4
5
6
7
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.